|
WO2009132172A1
|
|
Isoxazoline compounds and their use to suppress inflammation or treat inflammatory disease
|
|
WO2009111727A1
|
|
Compositions comprising ghrh and gnrh and methods of using the same
|
|
CN101702938A
|
|
Composition comprising high concentration of biologically active molecules and processes for preparing the same
|
|
CA2666501A1
|
|
Electroporation devices and methods of using same for electroporation of cells in mammals
|
|
CN101563132A
|
|
Electroporation devices and methods of using same for electroporation of cells in mammals
|
|
WO2006133198A2
|
|
Hsv drugs
|
|
US2009074721A1
|
|
Methods for treating viral infection with oral or injectibel drug solution
|
|
US2006188988A1
|
|
Optimized high yield synthetic plasmids
|
|
US2007259014A1
|
|
Compositions for and Methods for Treating Hiv
|
